Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature
- 23 January 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Archiv für Gynäkologie
- Vol. 287 (4), 733-741
- https://doi.org/10.1007/s00404-013-2715-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortBritish Journal of Cancer, 2011
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian CancerNew England Journal of Medicine, 2010
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trialsCancer, 2009
- Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR TrialAnnals of Surgical Oncology, 2006
- Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum‐sensitive epithelial ovarian carcinomaCancer, 2006
- Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancerGynecologic Oncology, 2006
- Intraperitoneal Cisplatin and Paclitaxel in Ovarian CancerNew England Journal of Medicine, 2006
- Cancer of the OvaryNew England Journal of Medicine, 2004
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002